Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database - Wikidata - awgldk - TriplyDB

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database

http://www.wikidata.org/entity/Q36977050

about

Treatment of colorectal cancer in the elderly Management of colorectal cancer Decision-making in geriatric oncology: systemic treatment considerations for older adults with colon cancer.Optimizing adjuvant therapy and survivorship care of stage III colon cancer.Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage III colon cancer: a population-based analysis.Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.Leveraging the power of pooled data for cancer outcomes research Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases.The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).S-1 as adjuvant chemotherapy for stage III colon cancer: a randomized phase III study (ACTS-CC trial).Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Chemotherapy for colorectal cancer in the elderly.Low-dose capecitabine adjuvant chemotherapy in elderly stage II/III colorectal cancer patients (LC-ACEC): study protocol for a randomized controlled trial.Overall Survival of Stage III Colon Cancer with Only One Lymph Node Metastasis Is Independently Predicted by Preoperative Carcinoembryonic Antigen Level and Lymph Node Sampling Status.Stage III Colon Cancer: The Individualized Strategy of Adjuvant Chemotherapy for Aged Under and Over 70 Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum.Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study.Chemotherapy use in stage III colon cancer: a National Cancer Database analysis Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.Adjuvant chemotherapy for colon cancer: a consensus statement of the Hellenic and Cypriot Colorectal Cancer Study Group by the HeSMO.Clinical Practice in the Use of Adjuvant Chemotherapy for Patients with Colon Cancer in South Korea: a Multi-Center, Prospective, Observational Study.Patterns of Colorectal Cancer Care in the United States: 1990-2010.Senior adult oncology.Comparative effectiveness of postoperative chemotherapy among older patients with non-metastatic rectal cancer treated with preoperative chemoradiotherapy.Prognostic Utility of Molecular Factors by Age at Diagnosis of Colorectal Cancer.Effectiveness of adjuvant chemotherapy for elderly patients with lymph node-positive colorectal cancer.Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy.Safety and effectiveness of oxaliplatin-based chemotherapy regimens in adults 75 years and older with colorectal cancer.Validity of Adjuvant! Online in older patients with stage III colon cancer based on 2967 patients from the ACCENT database.Challenges in the management of older patients with colon cancer Personalized surgical management of colorectal cancer in elderly population.To treat or not to treat: who should decide?Treatment of older patients with colorectal cancer: a perspective review.Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Determinants of recurrence after intended curative resection for colorectal cancer.Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.Controversies in the multimodality management of locally advanced rectal cancer.Trends in colorectal cancer in the elderly in Denmark, 1980-2012.

P2860

Q26781457-39C07FEC-E24F-42CD-90D2-9255EC865AC2 Q26823550-F603E25A-C183-46A8-830A-5E9D8670D9D4 Q30244769-56F09DDB-C4B4-4AF3-9EE8-E7A19D8EADC5 Q30249616-AA6F878B-A9F3-4CB3-884B-AEC6CC2747E4 Q30422095-9A283079-E187-4BE9-9FF7-E6EBD22F3FDB Q30422446-9A8DA5E2-2EE6-49F0-8EB2-887D34343CDF Q30884763-EFCB035B-4D91-419F-B954-9F6167C2F9D7 Q31119154-33E84B1D-0384-45FF-9314-BA613754FB5D Q33579145-08F50B81-9D92-4242-B505-77DD585BB386 Q33851067-5A32CBB7-DC16-4FD6-94F5-56AC700B1CA8 Q34083135-070AADB0-C19E-412F-87A5-12C1246915A7 Q34368278-FF5925CF-90AB-4660-9F9C-70F915B6D7DC Q34656360-354D3854-BF15-4205-A4FD-065D7153D836 Q35567604-DD671E25-8CBE-421F-B3B9-834A20C41EC8 Q35733020-D18ED4CE-5D58-4D4B-86E2-4008EF3253D7 Q35779359-E6D22B73-8BD4-4B75-AE76-4E61F1E8D26B Q35780153-77B37747-FC5F-433F-9A70-410AA9602942 Q35817933-A62A04C4-8066-4A4F-8E8D-E6316B5A2794 Q35920292-949914AC-7576-4B99-8B7B-F0C50EFC42CC Q35978879-E01BF11A-56E1-43C6-8DF1-D8F32ADC1F07 Q36154007-0CA12A4F-C630-4864-8931-28C2AEAEA159 Q36429095-FB1DF48E-96AC-42B6-8A82-69BF6F90758C Q36473901-4F626F8F-75FE-476B-B27B-61F4B8703F59 Q36824126-5BE52D1E-8FCB-4ACA-BBB4-9A912FAE980F Q36851424-4763B0DD-5E1E-41BC-A9EF-C8CC5BA5142F Q36913615-9CCE11FB-59A1-4EC5-B065-2301463FE3FC Q36954147-854A7F34-6A01-4A23-8E14-9431A72ACCAD Q37133361-90DDECD4-E72F-4D32-9384-3E834A6A475F Q37190135-DBDC981C-4776-4F9D-B1A9-23B376DD176C Q37242523-A99987CE-72B1-401D-8603-BAD016314A87 Q37507061-B83E9431-DB25-4198-955A-3727E59FFC3E Q37598467-A72EB7B7-7BC7-4612-9944-6516DACD9E37 Q37697526-1656464C-3C84-4389-9A1F-C6244F49DB6D Q37698196-DC2F84E6-0C4E-4823-9DFB-D11E0F2F4B55 Q37704350-486C3533-B116-4533-B9B6-90F773616518 Q38228522-EAC6B74D-91AC-48BA-851E-4772CA50D23D Q38265049-468E8876-5969-4870-8677-485A6BD38A40 Q38534405-31BFB458-C092-48DE-AE30-3E7ED7FBF8AF Q38691264-E3774BDD-B956-4081-8D9F-3B9D5988937C Q38920929-984A27E5-00AA-48FD-A526-621D6F025546

P2860

Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database

http://www.wikidata.org/entity/Q36977050

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Impact of age on the efficacy ...... dings from the ACCENT database

@en

type

label

Impact of age on the efficacy ...... dings from the ACCENT database

@en

prefLabel

Impact of age on the efficacy ...... dings from the ACCENT database

@en

P1433

Q36977050-77A20871-C1A7-4284-93DA-EDAB7657CB1E

P1476

Q36977050-50A4D955-502F-49BA-86F9-F0F9F4E54609

P2093

Q36977050-1ED12B4A-17A1-4169-982C-36D0FB12AAE6

Q36977050-2BC7C859-2BAC-441E-AB34-1FEE6D311189

Q36977050-395364F7-64B2-482D-8C00-191D41B039B6

Q36977050-64114C42-EAEF-4601-9CF2-EA16B0C0F68F

Q36977050-7C8387DA-D061-4BA0-AE83-0BDB72B2ED1D

Q36977050-990EE148-6E2B-4B09-89C2-E7DF80E8C525

Q36977050-D386CC7B-2251-443A-8642-40215E10D68B

Q36977050-F38698C4-E11F-414D-9CA2-4F46E02773F9

P2860

Q36977050-10410468-AFD3-4993-92CC-706430DCE479

Q36977050-28F90E01-83E1-4AA9-827A-6900DA8CA2F3

Q36977050-2DED3484-DFDC-4464-8EB7-04895A77F0B6

Q36977050-37A87D08-D262-44B2-884E-E397E715AEB4

Q36977050-3F7E252A-FD09-42E5-8127-0E41C84ABEA9

Q36977050-4743A26E-041D-4DE9-A91D-E71C2C5809E8

Q36977050-48EEDF71-072C-4F46-938B-ECCCE52EF0A9

Q36977050-529142CC-6114-49CB-B0A5-1D49139A8520

Q36977050-5356EB21-8F7E-498A-A96D-C00A0162B1B1

Q36977050-580B1223-DC8D-4317-B9F6-92526829C599

P304

Q36977050-D28FC8A3-0CB1-414D-96D2-E0850CD72741

P31

Q36977050-98FED47A-3B0F-4E2E-8E09-86768A883139

P356

Q36977050-3F9AF7F5-3C26-487D-A4B9-1326F7A5EB22

P407

Q36977050-2654BAB6-9738-4F38-B170-61E07D911212

P433

Q36977050-9D40C631-31B6-4ECA-9796-6B620ED94360

P478

Q36977050-580AE67F-0D9C-4615-9A0D-C375B0BB52D0

P50

Q36977050-66365A4B-4E71-41E3-993D-705AB2848C98

Q36977050-F8B5154F-5A32-400B-A966-BC4D32E3D7D4

Q36977050-FDC603B3-C944-42AE-B2BD-AA1279F079A0

P577

Q36977050-5E1E4EFE-42DE-4BDB-87A6-D18E4D226157

P5875

Q36977050-951A381E-B8F7-4D1C-8F9B-A0611C1CE57D

P698

Q36977050-4E246A0A-00DD-452A-9B9A-11963186FF8D

P921

Q36977050-9541CD24-0589-42A6-BC12-B8199B3E65AF

Q36977050-B8FC8AA2-1A54-4C53-8BE2-DED1BD233421

P932

Q36977050-4E388B1F-C5A8-409D-9101-224B6D31DBF6

P356

JCO.2013.49.6638

P1433

Journal of Clinical Oncology

P1476

Impact of age on the efficacy ...... dings from the ACCENT database

@en

P2093

Christopher J Twelves

http://www.w3.org/2001/XMLSchema#string

Daniel G Haller

http://www.w3.org/2001/XMLSchema#string

Daniel J Sargent

http://www.w3.org/2001/XMLSchema#string

Erin Green

http://www.w3.org/2001/XMLSchema#string

Greg Yothers

http://www.w3.org/2001/XMLSchema#string

Leonard B Saltz

http://www.w3.org/2001/XMLSchema#string

Michael O'Connell

http://www.w3.org/2001/XMLSchema#string

Nadine J McCleary

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Cancer statistics, 2010

Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.

Capecitabine plus oxaliplatin compared with fluorouracil and folinic acid as adjuvant therapy for stage III colon cancer.

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group.

Capecitabine as adjuvant treatment for stage III colon cancer.

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08.

The predictive value of self assessed general, physical, and mental health on functional decline and mortality in older adults.

P304

2600-2606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2013.49.6638

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Eric Van Cutsem

Aimery de Gramont

Jeffrey A Meyerhardt

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237017893

http://www.w3.org/2001/XMLSchema#string

P698

23733765

http://www.w3.org/2001/XMLSchema#string

P921

P932

3699725

http://www.w3.org/2001/XMLSchema#string